Study Comparing Two Types of Psychotherapy for Treating Depression and Substance Abuse
Study Details
Study Description
Brief Summary
The purpose of this study is to determine whether Integrated Cognitive Behavioral Therapy or Twelve Step Facilitation Therapy is most effective for treatment of dually diagnosed veterans with depressive and substance use disorders.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Depression is the most frequent co-occuring mental health disorder among adults with substance use disorders, and such comorbidity is often associated with poorer treatment outcomes. Although there is an urgent need for effective treatments specific for dual-diagnosis adults, few studies have been conducted to address this need.
Comparison: This study will compare substance use and depression symptoms of individuals in two different psychotherapy groups: Integrated Cognitive Behavioral Therapy and Twelve Step Facilitation Therapy. Symptoms and substance use will be compared during the active treatment phase (24 weeks) and for one year following the end of the active treatment.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: 1 Integrated Cognitive Behavioral Therapy |
Behavioral: Integrated Cognitive Behavioral Therapy
|
Experimental: 2 Twelve Step Facilitation Therapy |
Behavioral: Twelve Step Facilitation Therapy
|
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Inclusion Criteria:
- Individuals diagnosed with one or more substance use disorders (alcohol, cannabis, and or stimulant abuse/dependence) and an independent co-occurring depressive disorder (major depression or dysthymia) will be included.
Exclusion Criteria:
-
Individuals with substance induced mood disorders and individuals experiencing persistent psychotic symptoms.
-
Those with life threatening or unstable medical illness, neurological disorders, or inability to read will be excluded.
-
Individuals currently prescribed steroids, disulfiram, or long acting benzodiazepines will be excluded.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | VA San Diego Healthcare System, San Diego | San Diego | California | United States | 92161 |
Sponsors and Collaborators
- US Department of Veterans Affairs
Investigators
- Principal Investigator: Sandra Brown, PhD, VA San Diego Healthcare System, San Diego
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- MHBS-041-99Sa